Androgen receptor cross-talk with cell signalling pathways.
about
Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptorsTargeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathwayRestoration of PTEN expression alters the sensitivity of prostate cancer cells to EGFR inhibitors.Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancerMolecular alterations in primary prostate cancer after androgen ablation therapy.The expression of androgen-responsive genes is up-regulated in the epithelia of benign prostatic hyperplasiaAndrogen-responsive gene database: integrated knowledge on androgen-responsive genesBypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.Phosphorylation and activation of androgen receptor by Aurora-ACharacterization of androgen receptor structure and nucleocytoplasmic shuttling of the rice field eel.Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease.Neural protein gamma-synuclein interacting with androgen receptor promotes human prostate cancer progressionLycopene enhances docetaxel's effect in castration-resistant prostate cancer associated with insulin-like growth factor I receptor levels.Androgens and hypertension: role in both males and females?G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells.New hormonal therapies for castration-resistant prostate cancer.Frequent detection of infectious xenotropic murine leukemia virus (XMLV) in human cultures established from mouse xenografts.Mechanisms of acquired androgen independence during arsenic-induced malignant transformation of human prostate epithelial cells.Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer.The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate CancerPKA knockdown enhances cell killing in response to radiation and androgen deprivation.Unveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradation.p75 Neurotrophin Receptor Regulates Energy Balance in Obesity.Efficacy of maximal androgen blockade versus castration alone in the treatment of advanced prostate cancer: a retrospective clinical experience from a Chinese medical centre.Pleiotropic functional properties of androgen receptor mutants in prostate cancer.Gene Expression Profiling Reveals Regulation of ERK Phosphorylation by Androgen-Induced Tumor Suppressor U19/EAF2 in the Mouse Prostate.Interaction of gonadal steroids and gonadotropin-releasing hormone on pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP receptor expression in cultured rat anterior pituitary cellsEnhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells.Ligand-independent and tissue-selective androgen receptor inhibition by pyrvinium.Androgen regulation of prostate cancer: where are we now?IL-6/IL-6R as a potential key signaling pathway in prostate cancer development.Role of testosterone in the pathogenesis, progression, prognosis and comorbidity of men with chronic kidney disease.Targeting the relaxin hormonal pathway in prostate cancer.Insulin-like growth factor 1 stimulation of androgen receptor activity requires β(1A) integrins.Factors implicated in radiation therapy failure and radiosensitization of prostate cancer.miRNAs dysregulated in association with Gleason grade regulate extracellular matrix, cytoskeleton and androgen receptor pathways.Rationale for the development of alternative forms of androgen deprivation therapy.Associations of saposin C, Src, and androgen receptor upregulate the expression and function of androgen receptor in human prostate cancer cells.Human prostate cancer xenografts in lit/lit mice exhibit reduced growth and androgen-independent progression.Suppression of ErbB-2 in androgen-independent human prostate cancer cells enhances cytotoxic effect by gemcitabine in an androgen-reduced environment.
P2860
Q24308715-5EEE9719-A083-469F-8473-60BEDFD37AD9Q28382812-5D63B1CD-D55D-43E9-B205-227E8EB3B841Q30438487-C339167F-E720-4600-8A9B-A8A20BD3CD53Q30440162-19655A9A-9930-4587-9E47-F61BBF0C5587Q33224548-24A40091-493E-43C5-B1C6-112BEC36F652Q33493120-A1186A2D-CA6B-4B7F-B5D9-117573EA62B5Q33642138-BE2C0F48-B62E-41FE-8C27-216EFC00A1E1Q33728239-B6D19EE7-1341-4702-9358-CAEBC883E378Q34236635-60849E6A-3650-4966-9368-5B8D294B43CFQ34299330-B7B5EB97-5349-44F1-B0F4-E54A363EC9A5Q34457527-D0E924AA-8984-4BB1-B731-48A38FBEAA9BQ34508711-CC7FA312-8693-4D9C-934F-110612A456E7Q34551541-0EF56816-56F8-4122-AC18-6D036C3D0A6BQ34846555-3434A3F5-57D7-45CE-914C-4D46CC6482FBQ35127176-44D52175-D507-473C-B19D-48014AFC03A9Q35196715-9049FAEB-1FF2-4987-9A5F-1CEA5B195C2CQ35556465-4DC8324C-BFDB-4335-8FAF-257730BAB96BQ35672221-AA15B70C-BE12-44EE-A1C2-CCF8FA181C91Q35836876-4AB29815-86AE-42D8-A2A7-593F5DA37D08Q35882782-A3BF064B-CA60-4E8F-A8AB-20F5B58F4A49Q36081726-8E506FBF-79E9-443F-8830-627FEAC148DEQ36446486-D5759BE2-44BB-473D-A588-56273BE982EFQ36798728-8B971B40-A86E-403E-928B-EF9BF6F61AFEQ37084596-363275D5-DAF9-4B0A-916F-2F3CE1CF340CQ37272639-D0F58DAC-0F74-43C6-B948-86971D59BDBBQ37373807-90F7D7FC-1B07-4128-8B0F-5D1D3D1EF408Q37379800-63356D6A-BBDD-4CFD-BED7-4D6376F06186Q37424118-05449111-F4DA-44F2-9AD7-FFFA3BCC5A69Q37656304-AF341365-FB7A-494C-AE28-5B60782D6AD2Q37836264-47784F86-F17A-4585-B932-CA144FA1C87AQ37968599-C178E8A7-B5A2-4C98-9982-A83A42ECDAFEQ38151985-675644AF-E829-4356-923D-4985FD8DD594Q38231840-438D4785-3A94-46D2-AC20-255F9FE9E9E7Q38739702-963E1DBB-15D4-48BC-AD8F-7F46878A0568Q38807901-2E619126-8AF3-4B62-97F1-3BF8676C2736Q38870815-C0E2E80F-B739-4828-AB54-D027281A640BQ39342369-AEF3F622-6361-4C2D-912B-2C6B9A4CCF22Q39590597-6A0732FA-D403-4E0B-8A04-ABEC662FE879Q39650181-E3AD69BA-4E41-4F25-B69C-F6B013D35DBFQ39847370-5D3E3EDF-DC8C-421D-B0A9-EB2779B3E11B
P2860
Androgen receptor cross-talk with cell signalling pathways.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Androgen receptor cross-talk with cell signalling pathways.
@ast
Androgen receptor cross-talk with cell signalling pathways.
@en
type
label
Androgen receptor cross-talk with cell signalling pathways.
@ast
Androgen receptor cross-talk with cell signalling pathways.
@en
prefLabel
Androgen receptor cross-talk with cell signalling pathways.
@ast
Androgen receptor cross-talk with cell signalling pathways.
@en
P1476
Androgen receptor cross-talk with cell signalling pathways.
@en
P2093
Zoran Culig
P304
P356
10.1080/08977190412331279908
P577
2004-09-01T00:00:00Z